当前位置:首页 - 行情中心 - 索宝蛋白(603231) - 财务分析 - 现金流量表

索宝蛋白

(603231)

  

流通市值:19.80亿  总市值:35.67亿
流通股本:1.06亿   总股本:1.91亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,269,190,681.3774,628,905.1401,336,324.321,689,917,285.06
  收到的税费返还51,398,315.3934,268,039.7914,509,292.9564,053,774.36
  收到其他与经营活动有关的现金44,590,078.929,614,465.748,325,603.3439,305,706.31
  经营活动现金流入小计1,365,179,075.61818,511,410.63424,171,220.611,793,276,765.73
  购买商品、接受劳务支付的现金1,035,263,652.11676,267,894.88409,894,840.831,456,789,183.7
  支付给职工以及为职工支付的现金89,272,952.1562,303,117.6537,015,666.27103,715,232.19
  支付的各项税费41,434,208.2227,343,901.1313,977,278.6936,712,493.1
  支付其他与经营活动有关的现金70,183,473.0623,787,757.3119,167,854.7648,374,337.67
  经营活动现金流出小计1,236,154,285.54789,702,670.97480,055,640.551,645,591,246.66
  经营活动产生的现金流量净额129,024,790.0728,808,739.66-55,884,419.94147,685,519.07
二、投资活动产生的现金流量:
  取得投资收益收到的现金7,615,455.434,139,015.566,930,144.1210,816,629.52
  处置固定资产、无形资产和其他长期资产收回的现金净额187,210187,011.78-411,935.59
  收到的其他与投资活动有关的现金1,902,780,0001,274,380,000783,180,0001,508,710,000
  投资活动现金流入小计1,910,582,665.431,278,706,027.34790,110,144.121,519,938,565.11
  购建固定资产、无形资产和其他长期资产支付的现金89,868,075.2954,962,134.1737,813,968.06168,511,204.96
  支付其他与投资活动有关的现金2,058,809,444.441,260,909,444.44893,709,444.442,007,390,000
  投资活动现金流出小计2,148,677,519.731,315,871,578.61931,523,412.52,175,901,204.96
  投资活动产生的现金流量净额-238,094,854.3-37,165,551.27-141,413,268.38-655,962,639.85
三、筹资活动产生的现金流量:
  取得借款收到的现金47,548,00023,774,00023,774,00023,774,000
  筹资活动现金流入小计47,548,00023,774,00023,774,00023,774,000
  偿还债务支付的现金47,548,00023,774,00023,774,00083,774,000
  分配股利、利润或偿付利息支付的现金57,494,904.0157,498,564.98120,489.6895,904,677.99
  支付其他与筹资活动有关的现金1,292,821.031,052,821.03-93,568,972.47
  筹资活动现金流出小计106,335,725.0482,325,386.0123,894,489.68273,247,650.46
  筹资活动产生的现金流量净额-58,787,725.04-58,551,386.01-120,489.68-249,473,650.46
四、汇率变动对现金及现金等价物的影响7,013,825.837,497,128.961,740,972.574,628,003.85
五、现金及现金等价物净增加额-160,843,963.44-59,411,068.66-195,677,205.43-753,122,767.39
  加:期初现金及现金等价物余额320,021,347.41320,021,347.41320,021,347.411,073,144,114.8
  期末现金及现金等价物余额159,177,383.97260,610,278.75124,344,141.98320,021,347.41
补充资料:
  净利润-97,432,394.07-121,180,733.75
  资产减值准备--16,626.41-4,052,226.63
  固定资产和投资性房地产折旧-32,652,700.05-65,223,992.96
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-32,652,700.05-65,223,992.96
  无形资产摊销-1,031,264.7-3,361,921.41
  处置固定资产、无形资产和其他长期资产的损失-499,658.78-29,666.68
  固定资产报废损失-224,051.15-2,862,170.51
  公允价值变动损失--2,926,444.79--6,201,917.5
  财务费用-77,609.38-140,609.19
  投资损失--702,493.6--5,341,043.26
  递延所得税--326,878.29--1,157,960.85
  其中:递延所得税资产减少-19,337.71-123,395.36
    递延所得税负债增加--346,216--1,281,356.21
  存货的减少--6,473,890.82--68,312,954.74
  经营性应收项目的减少--18,782,796.71-10,112,997.07
  经营性应付项目的增加--67,320,046.24-29,676,150.13
  其他--7,497,128.96--4,622,822.26
  现金的期末余额-260,610,278.75-320,021,347.41
  减:现金的期初余额-320,021,347.41-1,073,144,114.8
  现金及现金等价物的净增加额--59,411,068.66--753,122,767.39
公告日期2025-10-312025-08-282025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑